Author Archives: daddy

Uncategorized

Retatrutide peptide

Posted on by daddy
10
Dec

Retatrutide peptide (LY3437943) is an investigational triple-hormone receptor agonist being developed by Eli Lilly and Company. It is not a simple peptide but a single synthetic peptide molecule engineered to simultaneously target three key metabolic receptors:GLP-1 Receptor (Glucagon-like peptide-1) – Increases insulin, decreases glucagon, slows gastric emptying, promotes satiety.GIP Receptor (Glucose-dependent insulinotropic polypeptide) – Enhances insulin secretion and may improve fat […]

Continue reading →
latest news

What Is Retatrutide

Posted on by daddy
What Is Retatrutide
16
Aug

What Is Retatrutide? The Next Breakthrough in Weight Loss and Diabetes Treatment Retatrutide is an experimental triple-hormone agonist developed by Eli Lilly, targeting the GIP, GLP-1, and glucagon receptors to enhance weight loss and blood sugar control. Early clinical trials show unprecedented results, with participants losing up to 24% of their body weight surpassing current drugs like Wegovy (semaglutide) […]

Continue reading →